Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

Shares of Sun Pharma are trading lower than 5-day, 10 day, 20-day, 30 day but higher than the 50-day, 100-day, 150 day, and ...

Sun Pharma the US health regulator has classified its Baska facility in Gujarat under Official Action Indicated (OAI) category following an inspection from September 8 to September 19, 2025.

Sun Pharma share price fell over 3% to ₹1,738 apiece on NSE in Thursday's trading session after the US Food and Drug ...

Shares of Sun Pharmaceutical Industries Ltd. are trading 2.4% lower on Thursday, December 18, after the US Food and Drug ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 advanced 1.16% to 1,806.90 Indian rupees Thursday, on what proved to be ...

Discover the Sun Pharma Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a top-performing stock. Keep track of Sun Pharma's latest details, including: Last ...

A trio of Indian drugmakers—Alembic Pharmaceuticals, Sun Pharmaceutical and Glenmark Pharmaceuticals—issued separate voluntary U.S. drug recalls in recent weeks due to either the presence of ...

In a dramatic change to Australian patent law, Australia's Full Federal Court has just held that patents for pharmaceutical formulations are not eligible for patent term extensions ( PTE ): Otsuka ...

Sun Pharma informed the stock exchanges that the board of directors of its subsidiary Sun Pharma Laboratories approved the investment proposal of ₹3,000 crore to set up a greenfield formulations ...

The Delhi High Court on Wednesday recorded Sun Pharmaceutical Industries Ltd.'s assurance that it will not sell its ...

Sun Pharma''s Baska facility in Gujarat receives OAI classification from USFDA after inspection. What does this mean for the ...